Sign in

CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
611547851
Phone
(858) 500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$1,239,000
in 1 filing
Open-market sales, last 90 days
$1,708,041
in 8 filings, $650K under 10b5-1 plans

Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-29 FORD KATHLEEN Chief Operating Officer Sale 10b5-1 −3,668 $10.75 $39K 142,986
2026-09-29 Leoni Mollie Chief Medical Officer Sale −28,802 $10.75 $310K 141,095
2026-09-29 Powl Brian T. Chief Commercial Officer Sale −15,430 $10.75 $166K 136,819
2026-09-28 Bair Teresa Brophy Chief Legal Officer Sale 10b5-1 −8,442 $10.50 $89K 187,002
2026-09-28 FORD KATHLEEN Chief Operating Officer Sale 10b5-1 −6,906 $10.50 $72K 146,654
2026-09-28 Leoni Mollie Chief Medical Officer Sale −12,448 $10.50 $131K 169,897
2026-09-28 DOYLE THOMAS JAMES SVP, Finance & Accounting Sale −4,607 $10.50 $48K 142,428
2026-09-28 Powl Brian T. Chief Commercial Officer Sale −9,020 $10.50 $95K 160,249
2026-09-28 Powl Brian T. Chief Commercial Officer Sale −8,000 $10.56 $84K 152,249
2026-09-24 Burrows Francis Chief Scientific Officer Option exercise +30,000 $6.15 $185K 63,053
2026-09-24 Burrows Francis Chief Scientific Officer Sale −20,726 $10.83 $225K 42,327
2026-09-24 Burrows Francis Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −30,000 0
2026-09-08 Fulk Jennifer Chief Financial Officer Grant or award · Option to purchase common stock 10b5-1 +450,000 450,000
2026-08-24 WILSON TROY EDWARD President and CEO Purchase +100,000 $12.39 $1.2M 479,194
2026-08-21 Powl Brian T. Chief Commercial Officer Sale 10b5-1 −4,345 $11.89 $52K 169,269
2026-08-19 Bair Teresa Brophy Chief Legal Officer Sale 10b5-1 −31,487 $12.63 $398K 195,444
2026-08-17 WILSON TROY EDWARD President and CEO Purchase +100,000 $11.12 $1.1M 379,194
2026-06-18 Leoni Mollie Chief Medical Officer Sale 10b5-1 −84,929 $9.82 $834K 182,345
2026-06-04 Parks Diane L. Director Grant or award · Option to purchase common stock +35,000 35,000
2026-06-04 VASCONCELLES MICHAEL Director Grant or award · Option to purchase common stock +35,000 35,000

Page 1 of 9 · 164 trades